Wright HR et al. |
Elimination of trachoma: are we in danger of being blinded by the randomised controlled trial? |
2006 |
Br J Ophthalmol |
pmid:17057171
|
Ngondi J et al. |
Estimation of effects of community intervention with antibiotics, facial cleanliness, and environmental improvement (A,F,E) in five districts of Ethiopia hyperendemic for trachoma. |
2010 |
Br J Ophthalmol |
pmid:19897474
|
De Sole G |
Elimination of trachoma. |
1997 |
Br J Ophthalmol |
pmid:9274426
|
Mabey D and Bailey R |
Eradication of trachoma worldwide. |
1999 |
Br J Ophthalmol |
pmid:10535853
|
Chern KC et al. |
Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area. |
1999 |
Br J Ophthalmol |
pmid:10574809
|
Kashkouli MB et al. |
Oral azithromycin versus doxycycline in meibomian gland dysfunction: a randomised double-masked open-label clinical trial. |
2015 |
Br J Ophthalmol |
pmid:25138765
|
Zhang H et al. |
Impact of oral azithromycin on recurrence of trachomatous trichiasis in Nepal over 1 year. |
2006 |
Br J Ophthalmol |
pmid:16687452
|
Gaynor BD et al. |
Topical ocular antibiotics induce bacterial resistance at extraocular sites. |
2005 |
Br J Ophthalmol |
pmid:16113356
|
Chidambaram JD and Lietman TM |
Trachoma. |
2005 |
Br J Ophthalmol |
pmid:16170104
|
Burton MJ et al. |
A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia. |
2005 |
Br J Ophthalmol |
pmid:16170117
|
Lietman T and Fry A |
Can we eliminate trachoma? |
2001 |
Br J Ophthalmol |
pmid:11264123
|
Thylefors B |
Trachoma--new opportunities to tackle an old problem. |
1996 |
Br J Ophthalmol |
pmid:9059262
|
Huguet P et al. |
Mass treatment of trachoma with azithromycin 1.5% eye drops in the Republic of Cameroon: feasibility, tolerance and effectiveness. |
2010 |
Br J Ophthalmol |
pmid:19692356
|
Cochereau I et al. |
Efficacy and safety of short duration azithromycin eye drops versus azithromycin single oral dose for the treatment of trachoma in children: a randomised, controlled, double-masked clinical trial. |
2007 |
Br J Ophthalmol |
pmid:17005549
|
Bremond-Gignac D et al. |
Efficacy and safety of azithromycin 1.5% eye drops in paediatric population with purulent bacterial conjunctivitis. |
2014 |
Br J Ophthalmol |
pmid:24526744
|
Rothova A et al. |
Azithromycin for ocular toxoplasmosis. |
1998 |
Br J Ophthalmol |
pmid:9924338
|
Steeples LR et al. |
Real-time PCR using the 529 bp repeat element for the diagnosis of atypical ocular toxoplasmosis. |
2016 |
Br J Ophthalmol |
pmid:26174811
|
Javaloy J et al. |
Follicular conjunctivitis caused by Chlamydia trachomatis in an infant Saharan population: molecular and clinical diagnosis. |
2003 |
Br J Ophthalmol |
pmid:12543737
|
Gaynor BD et al. |
Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year. |
2003 |
Br J Ophthalmol |
pmid:12543738
|
Taylor KI and Taylor HR |
Distribution of azithromycin for the treatment of trachoma. |
1999 |
Br J Ophthalmol |
pmid:10396186
|
Cochereau I et al. |
3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children. |
2007 |
Br J Ophthalmol |
pmid:17050578
|
Jucglà A et al. |
The use of azithromycin for cyclosporin-induced gingival overgrowth. |
1998 |
Br. J. Dermatol. |
pmid:9536254
|
Raja Babu KK et al. |
Confluent and reticulate papillomatosis: successful treatment with azithromycin. |
2000 |
Br. J. Dermatol. |
pmid:10848767
|
Schwartz RA et al. |
Bacillary angiomatosis in an HIV seronegative patient on systemic steroid therapy. |
1996 |
Br. J. Dermatol. |
pmid:8977724
|
Thomsen MB et al. |
No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block. |
2006 |
Br. J. Pharmacol. |
pmid:17088870
|
VranÄić M et al. |
Azithromycin distinctively modulates classical activation of human monocytes in vitro. |
2012 |
Br. J. Pharmacol. |
pmid:21726210
|
Broad J and Sanger GJ |
The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin. |
2013 |
Br. J. Pharmacol. |
pmid:23190027
|
Balloy V et al. |
Azithromycin analogue CSY0073 attenuates lung inflammation induced by LPS challenge. |
2014 |
Br. J. Pharmacol. |
pmid:24417187
|
Marks M et al. |
Yaws. |
2015 |
Br. Med. Bull. |
pmid:25525120
|
Péc J et al. |
[Treatment of chlamydia infections and a brief review of the problems]. |
1995 |
Bratisl Lek Listy |
pmid:7633932
|
Rubio FG et al. |
Intravenous azithromycin plus ceftriaxone followed by oral azithromycin for the treatment of inpatients with community-acquired pneumonia: an open-label, non-comparative multicenter trial. |
2008 |
Braz J Infect Dis |
pmid:18833404
|
Belda Jr W et al. |
A comparative study of single-dose treatment of chancroid using thiamphenicol versus Azithromycin. |
2009 |
Braz J Infect Dis |
pmid:20191200
|
Sader H and Del'Alamo L |
Etest compared to broth microdilution: discrepant results when testing macrolides against Streptococcus pneumoniae indicate a need for better clinical and serum level/MIC correlation. |
2000 |
Braz J Infect Dis |
pmid:11063559
|
Khan FY and A yassin M |
Mycoplasma pneumoniae associated with severe autoimmune hemolytic anemia: case report and literature review. |
2009 |
Braz J Infect Dis |
pmid:19578637
|
Mendes CM et al. |
In vitro susceptibility of gram-positive cocci isolated from skin and respiratory tract to azithromycin and twelve other antimicrobial agents. |
2001 |
Braz J Infect Dis |
pmid:11779453
|
Ferreira CP et al. |
Atypical cutaneous mycobacteriosis caused by Mycobacterium avium complex. |
2010 May-Jun |
Braz J Infect Dis |
pmid:20835523
|
Oliveira IS et al. |
Evaluation of the improvement of quality of life with Azithromycin in the treatment of eosinophilic nasal polyposis. |
2016 Mar-Apr |
Braz J Otorhinolaryngol |
pmid:26601998
|
Haas AN et al. |
Predictors of clinical outcomes after periodontal treatment of aggressive periodontitis: 12-month randomized trial. |
2016 |
Braz Oral Res |
pmid:27223128
|
Narita M et al. |
Antimicrobial Susceptibility of Microorganisms Isolated from Periapical Periodontitis Lesions. |
2016 |
Bull. Tokyo Dent. Coll. |
pmid:27665691
|
Burr SE et al. |
Mass administration of azithromycin and Streptococcus pneumoniae carriage: cross-sectional surveys in the Gambia. |
2014 |
Bull. World Health Organ. |
pmid:25110374
|
Solomon AW et al. |
Pilot study of the use of community volunteers to distribute azithromycin for trachoma control in Ghana. |
2001 |
Bull. World Health Organ. |
pmid:11217675
|
Fraser-Hurt N et al. |
Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma. |
2001 |
Bull. World Health Organ. |
pmid:11477966
|
Frick KD et al. |
Household willingness to pay for azithromycin treatment for trachoma control in the United Republic of Tanzania. |
2003 |
Bull. World Health Organ. |
pmid:12751418
|
Holm SO et al. |
Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal. |
2001 |
Bull. World Health Organ. |
pmid:11285662
|
Frick KD et al. |
Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children. |
2001 |
Bull. World Health Organ. |
pmid:11285663
|
Emerson PM et al. |
The SAFE strategy for trachoma control: Using operational research for policy, planning and implementation. |
2006 |
Bull. World Health Organ. |
pmid:16917648
|
Bailey R and Lietman T |
The SAFE strategy for the elimination of trachoma by 2020: will it work? |
2001 |
Bull. World Health Organ. |
pmid:11285668
|
Lück PC and Steinert M |
[Pathogenesis, diagnosis and therapy of Legionella infections]. |
2006 |
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz |
pmid:16596363
|
Boyer JM et al. |
Nontuberculous mycobacterium infection in a burn ICU patient. |
2010 |
Burns |
pmid:20594758
|
Yu T and Niu T |
Giant inverted T waves and substantial QT interval prolongation induced by azithromycin in an elderly woman with renal insufficiency. |
2014 |
Can Fam Physician |
pmid:25392441
|
Gesink D et al. |
Mycoplasma genitalium in Toronto, Ont: Estimates of prevalence and macrolide resistance. |
2016 |
Can Fam Physician |
pmid:27331225
|
Pogany L et al. |
Management of gonococcal infection among adults and youth: New key recommendations. |
2015 |
Can Fam Physician |
pmid:26472793
|
Abbass K et al. |
Mycobacterium fortuitum breast abscess after nipple piercing. |
2014 |
Can Fam Physician |
pmid:24452562
|
|
Emerging risk of untreatable gonorrhea and what to do about it. |
2017 |
Can Fam Physician |
pmid:28292798
|
Sirois F |
[Delirium associated with azithromycin administration]. |
2002 |
Can J Psychiatry |
pmid:12211892
|
Rekart M et al. |
Mass treatment/prophylaxis during an outbreak of infectious syphilis in Vancouver, British Columbia. |
2000 |
Can. Commun. Dis. Rep. |
pmid:10932390
|
Yoh M et al. |
Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. |
1999 |
Can. J. Microbiol. |
pmid:10526400
|
Weinstein O et al. |
Bilateral acute anterior uveitis as a presenting symptom of Mycoplasma pneumoniae infection. |
2006 |
Can. J. Ophthalmol. |
pmid:17016530
|
Basque J et al. |
Lysosomotropic drugs inhibit maturation of transforming growth factor-beta. |
2008 |
Can. J. Physiol. Pharmacol. |
pmid:18758509
|
Melnichouk S et al. |
Evaluation of lansoprazole (an H+/K+-ATPase inhibitor) and azithromycin (an antibiotic) for control of gastric ulceration in swine during periods of feed deprivation. |
1999 |
Can. J. Vet. Res. |
pmid:10534003
|
Baumann U et al. |
Long term azithromycin therapy in cystic fibrosis patients: a study on drug levels and sputum properties. |
2004 |
Can. Respir. J. |
pmid:15045047
|
Porhownik NR et al. |
Effect of maintenance azithromycin on established bronchiolitis obliterans syndrome in lung transplant patients. |
2008 May-Jun |
Can. Respir. J. |
pmid:18551201
|
Weiss K et al. |
Clinical characteristics at initial presentation and impact of dual therapy on the outcome of bacteremic Streptococcus pneumoniae pneumonia in adults. |
2004 Nov-Dec |
Can. Respir. J. |
pmid:15611810
|
Zhang M et al. |
Electrophysiologic Studies on the Risks and Potential Mechanism Underlying the Proarrhythmic Nature of Azithromycin. |
2017 |
Cardiovasc. Toxicol. |
pmid:28213753
|
Ohara H et al. |
Azithromycin Can Prolong QT Interval and Suppress Ventricular Contraction, but Will Not Induce Torsade de Pointes. |
2015 |
Cardiovasc. Toxicol. |
pmid:25367413
|
Cocco G and Jerie P |
Torsades de pointes induced by the concomitant use of ivabradine and azithromycin: an unexpected dangerous interaction. |
2015 |
Cardiovasc. Toxicol. |
pmid:25158669
|
Tu D et al. |
Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance. |
2005 |
Cell |
pmid:15851032
|
Willems-Widyastuti A et al. |
Azithromycin attenuates fibroblast growth factors induced vascular endothelial growth factor via p38(MAPK) signaling in human airway smooth muscle cells. |
2013 |
Cell Biochem. Biophys. |
pmid:22205500
|
Tanyuksel M et al. |
Determination of intracellular efficacies of azithromycin against Leishmania major infection in human neutrophils in vitro. |
2003 |
Cell Biochem. Funct. |
pmid:12579528
|
Nujić K et al. |
Impairment of lysosomal functions by azithromycin and chloroquine contributes to anti-inflammatory phenotype. |
2012 |
Cell. Immunol. |
pmid:23099154
|
Castor D et al. |
Antibiotic resistant N. gonorrhoeae in Trinidad and Tobago. |
2001 |
Cell. Mol. Biol. (Noisy-le-grand) |
pmid:11785665
|
Li Y et al. |
Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo. |
2017 |
Cell. Physiol. Biochem. |
pmid:28738346
|
Jakubů V et al. |
Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015. |
2017 |
Cent. Eur. J. Public Health |
pmid:29346850
|
Sobek A et al. |
[Prevalence of Chlamydia trachomatis infection in patients treated for infertility]. |
2012 |
Ceska Gynekol |
pmid:23116355
|
Pavlova A et al. |
Toward the rational design of macrolide antibiotics to combat resistance. |
2017 |
Chem Biol Drug Des |
pmid:28419786
|
Sanchez Garcia D et al. |
Cellular accumulation and lipid binding of perfluorinated alkylated substances (PFASs) - A comparison with lysosomotropic drugs. |
2018 |
Chem. Biol. Interact. |
pmid:29248446
|
Tsuji E et al. |
Evaluation of bitterness suppression of macrolide dry syrups by jellies. |
2006 |
Chem. Pharm. Bull. |
pmid:16508183
|
Fa N et al. |
Effect of the antibiotic azithromycin on thermotropic behavior of DOPC or DPPC bilayers. |
2006 |
Chem. Phys. Lipids |
pmid:17007828
|
Fu L et al. |
Toxicity of 13 different antibiotics towards freshwater green algae Pseudokirchneriella subcapitata and their modes of action. |
2017 |
Chemosphere |
pmid:27783962
|
Vermillion Maier ML and Tjeerdema RS |
Azithromycin sorption and biodegradation in a simulated California river system. |
2018 |
Chemosphere |
pmid:29031188
|
Tong L et al. |
Photodegradation of azithromycin in various aqueous systems under simulated and natural solar radiation: kinetics and identification of photoproducts. |
2011 |
Chemosphere |
pmid:21220145
|
Ripa S et al. |
A linear model for the pharmacokinetics of azithromycin in healthy volunteers. |
1996 Nov-Dec |
Chemotherapy |
pmid:8957574
|
Hauke W et al. |
Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study. |
2002 |
Chemotherapy |
pmid:12476043
|
Marrie TJ |
Experience with levofloxacin in a critical pathway for the treatment of community-acquired pneumonia. |
2004 |
Chemotherapy |
pmid:15319549
|
Minguez F et al. |
In vitro killing kinetics and postantibiotic effect of josamycin and other macrolides on several bacteria. |
1993 May-Jun |
Chemotherapy |
pmid:8389685
|
Chakrabarti MK et al. |
Evaluation of different antibiotics in inhibiting colonization of Vibrio cholerae O1 and O139 in the rabbit intestine. |
1998 Mar-Apr |
Chemotherapy |
pmid:9551241
|
Vranes J |
Effect of subinhibitory concentrations of ceftazidime, ciprofloxacin, and azithromycin on the hemagglutination and adherence of uropathogenic Escherichia coli strains. |
1996 May-Jun |
Chemotherapy |
pmid:8983884
|
Ichimiya T et al. |
The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro. |
1996 May-Jun |
Chemotherapy |
pmid:8983885
|
Galova K et al. |
Multicenter randomized study of two once daily regimens in the initial management of community-acquired respiratory tract infections in 163 children: azithromycin versus ceftibuten. |
1996 May-Jun |
Chemotherapy |
pmid:8983893
|
Wenzler S et al. |
Comparative in vitro activities of three new quinolones and azithromycin against aerobic pathogens causing respiratory tract and abdominal wound infections. |
2004 |
Chemotherapy |
pmid:15084805
|
Scaglione F et al. |
In vitro comparative dynamics of modified-release clarithromycin and of azithromycin. |
2000 Sep-Oct |
Chemotherapy |
pmid:10965100
|
Qadri SM et al. |
Antibacterial activity of azithromycin against Brucella melitensis. |
1995 Jul-Aug |
Chemotherapy |
pmid:7555205
|
Kalenić S et al. |
Helicobacter pylori: in vitro induction of resistance to azithromycin. |
1998 Jan-Feb |
Chemotherapy |
pmid:9444404
|
Lang R et al. |
Therapeutic effects of roxithromycin and azithromycin in experimental murine brucellosis. |
1994 Jul-Aug |
Chemotherapy |
pmid:8082413
|
Scaglione F et al. |
A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells. |
1993 Nov-Dec |
Chemotherapy |
pmid:8222870
|
Braga PC and Piatti G |
Interference by subinhibitory concentrations of azithromycin with the mechanism of bacterial adhesion to human epithelial cells. |
1993 Nov-Dec |
Chemotherapy |
pmid:8222872
|
Yourassowsky E et al. |
Rate of bactericidal activity for Branhamella catarrhalis of a new macrolide, CP-62,993, compared with that of amoxicillin-clavulanic acid. |
1988 |
Chemotherapy |
pmid:2843324
|
Fontán PA et al. |
Haemophilus influenzae type b exoproducts induce chemotaxis and macrolide antibiotic release by human polymorphonuclear leukocytes. |
1996 Jan-Feb |
Chemotherapy |
pmid:8751269
|
Bhengraj AR et al. |
Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India. |
2010 |
Chemotherapy |
pmid:20938174
|
Skerk V et al. |
Comparative randomized pilot study of azithromycin and doxycycline efficacy and tolerability in the treatment of prostate infection caused by Ureaplasma urealyticum. |
2006 |
Chemotherapy |
pmid:16340190
|